3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Retinal Vasculitis: new trials by email Literature Review of Retinal Vasculitis trials Research Report on Retinal Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
| Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease Rituximab, Cytotoxic Combination - Behcet's Syndrome | Phase 2 | Completed | Tehran University of Medical Sciences | 20 | 2006-04-01 | 2008-04-30 |
| HAT in Eye Complications of Behcet's Disease Daclizumab - Behcet's Syndrome, Retinal Disease | Phase 2 | Completed | National Eye Institute (NEI) | 26 | 1999-07-01 | 2008-03-04 |
Behcet Syndrome (3) · Uveitis (2) · Birdshot Chorioretinopathy (1) · Diabetes Mellitus, Insulin-Dependent, 10 (1) · Multifocal Choroiditis (1) · Ophthalmia, Sympathetic (1) · Panuveitis (1) · Retinal Diseases (1) · Sarcoidosis (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1)
Cardiovascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Eye Diseases (3) · Genetic Diseases, Inborn (3) · Hereditary Autoinflammatory Diseases (3) · Mouth Diseases (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Stomatognathic Diseases (3) · Uveal Diseases (3) · Uveitis, Anterior (3) · Vascular Diseases (3) · Vasculitis (3)
Cyclophosphamide (1) · Daclizumab (1) · Rituximab (1) · secukinumab (1)
National Eye Institute (NEI) (1) · Novartis Pharmaceuticals (1) · Tehran University of Medical Sciences (1)
United States (2) · Germany (1) · Iran (1)
Bahar Sadeghi, MD (1) · Cheyda Chams-Davatchi, MD (1) · Farhad Shahram, MD (1) · Fereydoun Davatchi, MD (1) · Hormoz Shams, MD (1) · Mozhgan Rezaipoor, MD (1)